Heart Disease Clinical Trials in Salt Lake City

Showing 81-100 of 338 trials

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

NCT05826925

Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.

Hypertension, Pregnancy InducedHypertension Complicating PregnancyPreeclampsia+2 more

University of Utah30 participantsStarted Feb 2025

Salt Lake City, Utah, United States

Active Not RecruitingNA< 1 mile

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

NCT04591392

Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect

Heart Septal DefectHeart Septal Defects, AtrialHeart Defects, Congenital+4 more

atHeart Medical250 participantsStarted Mar 2021

Birmingham, Alabama, United States • Los Angeles, California, United States • Thousand Oaks, California, United States +29 more locations

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Heart Disease Trials in Other Cities

A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Optisure Lead Post Approval Study

Hemodynamic-GUIDEd Management of Heart Failure

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Long Term Follow Up for CTSN Mitral Valve Repair Studies

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Abbott Vascular Medical Device Registry

Hybrid Coronary Revascularization Trial

SURPASS Impella 5.5 Study

Heart Failure Optimization Study

Global Utilization And Registry Database for Improved heArt preservatioN

Effect of Fetal Aortic Valvuloplasty on Outcomes

Other Conditions in Salt Lake City